Compare HBIO & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBIO | UCL |
|---|---|---|
| Founded | 1901 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Telecommunications Equipment |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 27.8M |
| IPO Year | 2000 | 2019 |
| Metric | HBIO | UCL |
|---|---|---|
| Price | $7.93 | $0.38 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 19.3K | ★ 1.3M |
| Earning Date | 05-12-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,176,000.00 | N/A |
| Revenue This Year | $4.77 | $11.60 |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.34 |
| 52 Week High | $7.90 | $3.58 |
| Indicator | HBIO | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 78.01 | 25.48 |
| Support Level | $5.91 | N/A |
| Resistance Level | N/A | $0.99 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 100.00 | 4.59 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.